Ramipril and Body height decreased - a phase IV clinical study of FDA data

Summary:

Body height decreased is reported as a side effect among people who take Ramipril (ramipril), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lyrica, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Body height decreased when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Body height decreased?

Body height decreased is found to be associated with 888 drugs and 982 conditions by eHealthMe. Check the latest studies of Body height decreased.

On Aug, 07, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 62 people (0.04%) have Body height decreased.

Could Ramipril cause Body height decreased?

Among these 62 people:

How long have people been on Ramipril when they have Body height decreased? *

What is the gender of people who have Body height decreased when taking Ramipril? *

female: 78.69 %
male: 21.31 %

What is the age of people who have Body height decreased when taking Ramipril? *

What are other drugs people take besides Ramipril? *

What are other side effects people have besides Body height decreased? *

Joint Pain: 11 people, 17.74%
Dyspnea (difficult or laboured breathing): 10 people, 16.13%
Drug Ineffective: 10 people, 16.13%
Pain: 10 people, 16.13%
Heart Attack: 8 people, 12.90%
Weight Decreased: 8 people, 12.90%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 7 people, 11.29%
Weakness: 7 people, 11.29%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 11.29%
Pain In Extremity: 6 people, 9.68%

What are the existing conditions these people have? *

High Blood Cholesterol: 13 people, 20.97%
Depression: 11 people, 17.74%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 12.90%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 12.90%
Type 2 Diabetes: 6 people, 9.68%
Cardiac Disorder: 6 people, 9.68%
Asthma: 6 people, 9.68%
Osteoporosis (bones weak and more likely to break): 6 people, 9.68%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 5 people, 8.06%
Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 8.06%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Body height decreased?

- Check whether Body height decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Body height decreased:

Body height decreased (888 drugs)

Browse all the conditions that are associated with Body height decreased:

Body height decreased (982 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.